Indaptus Therapeutics Entered Into Securities Purchase Agreements With Investors For The Issuance And Sale Of An Aggregate Of 1,643,837 Of Its Common Shares For A Gross Proceed Of $3.0M
Portfolio Pulse from Benzinga Newsdesk
Indaptus Therapeutics has entered into securities purchase agreements with investors for the issuance and sale of 1,643,837 common shares, raising $3.0 million in gross proceeds.
August 07, 2024 | 11:22 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Indaptus Therapeutics has raised $3.0 million through the issuance and sale of 1,643,837 common shares.
The successful raising of $3.0 million in gross proceeds through the sale of common shares is a positive development for Indaptus Therapeutics, providing additional capital for operations and growth. This could lead to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100